Application of the Health Action Process Approach Model Program to Patients With Heart Attacks
Launched by TC ERCIYES UNIVERSITY · Apr 23, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special program designed to help heart attack patients recover and improve their health. The program, called the Health Action Process Approach Model, is led by nurses and aims to support patients who have had a heart attack in making positive lifestyle changes. The trial will include 70 participants, divided into two groups: one group will receive the health program, while the other will not receive any additional support. Researchers will collect information at different times over six months to see how effective the program is in helping patients recover.
To be eligible for this trial, participants should be between 18 and 70 years old, have experienced a heart attack within the past month, and have no serious health issues that would limit their ability to participate. They should also be able to communicate well and live in the city center. Participants can expect to engage in a structured rehabilitation program that focuses on improving their overall health after a heart attack. This trial is currently not recruiting, but it aims to provide valuable insights into how structured support can help heart attack survivors lead healthier lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • To be between 18-70 years old,
- • Becoming literate,
- • Living in the city center
- • Having had a heart attack within the last month,
- • Not having had a heart attack before,
- • Dyspnea less than 4-5 degrees according to the modified Borg Scale
- • No deformity or diagnosis related to the musculoskeletal system that may prevent physical activity, no orthopedic limitation
- • Stable New York Heart Association (NHYA) functional class I or II coronary artery disease with myocardial infarction
- Exclusion Criteria:
- • Those with communication disabilities such as speech, vision, hearing
- • Dyspnea score of more than 4-5 degrees according to the modified Borg Scale
- • Those who stayed in intensive care for a long time after MI
- • Complications related to treatment and interventions after MI
- • Those who underwent surgical treatment after MI,
- • Those with chronic diseases (chronic obstructive pulmonary disease, chronic renal failure, hypertension, diabetes, pulmonary emphysema, rheumatic valve disease, cancer diagnosis, etc.)
- • Those who indicated that they would not participate in intervention programs due to time constraints.
- • Failure of the six-minute walk test
About Tc Erciyes University
TC Erciyes University is a leading academic institution in Turkey, dedicated to advancing medical research and healthcare through innovative clinical trials. With a strong emphasis on scientific excellence and collaboration, the university leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies aimed at improving patient outcomes. Committed to ethical standards and regulatory compliance, TC Erciyes University fosters a research environment that promotes the development of new therapies and interventions, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported